ArticleJournal of blood medicine2021

Efficacy of rFVIIIFc versus Emicizumab for the Treatment of Patients with Hemophilia A without Inhibitors: Matching-Adjusted Indirect Comparison of A-LONG and HAVEN Trials.

Robert Klamroth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.